Corporate Patient
PDMS Log In nSight Log In

HOW IT WORKS

Life-Changing Outcomes. Confident Care.

The RNS® System recognizes and responds to your patient's unique brain patterns to stop seizures before they start.

  1. Monitors

    Monitors patient's brain activity 24 hours a day, everyday

  2. Detects & Responds

    To your patient's unique seizure patterns to prevent seizures before they start in real time

  3. Records & Reports

    Ongoing iEEG data to help personalize care

Patient Selection

Every focal DRE patient should be evaluated for the RNS System.

Get Started

RNS Indication

  • 18+ years of age
  • Refractory to two or more medications
  • Focal Epilepsy with 1-2 seizure foci

Who Can Benefit from the RNS® System:

  • Patients who do not want a destructive brain surgery
  • Patients who are not a candidate for destructive surgery
  • Have not achieved seizure control with VNS or destructive surgery
Get Started

Learn More About The RNS System

Life changing outcomes

Unmatched seizure control that lets your patients take back their lives

Confident Care

Simplified iEEG insights help you confidently manage your patients' epilepsy care

Easily get your patients started with The RNS® System

Whether you're evaluating your first candidate or you want to establish the RNS System as your standard of care, we are here to help.

Contact NeuroPace Find a Center

Rx Only. The RNS® System is an adjunctive therapy for adults with refractory, partial onset seizures with no more than 2 epileptogenic foci. See important prescribing and safety information at www.NeuroPace.com/safety. Refer to the labeling for a description of the RNS System and its components, indications for use, contraindications, warnings, cautions, adverse events and instructions for use.

  1. RNS System Post-approval Study Oral Presentation, American Academy of Neurology, April 2025, all outcomes are ITT, median seizure reduction is observed case data.
  2. Morris et al, Neurology, 1999.
  3. Kaufmann et al., Epilepsia, 2024

Note: Therapies were studied using different study designs. Caution must be exercised when comparing results.

  1. Quraishi, et al, Epilepsia, 2020